3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gastrointestinal
1
Dermatologic
1
Conditions
Pancreatic Neoplasms
50
Colorectal Neoplasms
39
Stomach Neoplasms
27
Carcinoma, Hepatocellular
26
Ovarian Neoplasms
25
Melanoma
21
Breast Neoplasms
20
Carcinoma, Non-Small-Cell Lung
19
Neoplasms
15
Neoplasm Metastasis
15
Colonic Neoplasms
14
Esophageal Neoplasms
13
Uterine Cervical Neoplasms
11
Sarcoma
10
Liver Neoplasms
10
Carcinoma, Renal Cell
10
Lung Neoplasms
9
Anus Neoplasms
9
Rectal Neoplasms
8
Head and Neck Neoplasms
8
Squamous Cell Carcinoma of Head and Neck
7
Osteosarcoma
7
Triple Negative Breast Neoplasms
6
Mesothelioma
6
Hepatoblastoma
6
Gastrointestinal Neoplasms
6
Carcinoma
6
Adenocarcinoma
6
Vaginal Neoplasms
5
Small Cell Lung Carcinoma
5
Interventions
pembrolizumab
1
Imatinib Mesylate
1
Histamine H2 Antagonists
1
HhAntag691
1
Famotidine
1
Cyclophosphamide
1
Blood Specimen Collection
1
Angptl4 protein, mouse
1
2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Dermatofibrosarcoma
×
Cyclophosphamide
×
Gastrointestinal
×
Clear all
NCT01046487
2026-03-13
PALANGI3
Centre Oscar Lambret
Phase 1
Completed
26 enrolled